News


 
iso9001 certified
iso14001 certified

January 2025: Sickle Cell Treatment Our production of the plant material required for our  sickle cell treatment is being ramped up for a Phase 3 double blind cross-over trial in 2025.  A total of 44 acres of land has been purchased to grow the plants, with a dedicated staff of four full time people providing the husbandry.
October 2024: Ventilator Validation Deep Life Group's UK arm, Open Safety Equipment Ltd, has released its latest respiratory simulator, iBreathe MkIV, providing automated tested of VWAICO2, WOB and other key parameters in real time. This tool provides rapid validation of ventilator performance. For more information: Click here
February 2024: Phase 2 Clinical Trial Success for Anugel(™) A randomised clinical tria completed in on 110 patients, found that Anugel(™) cuts the need for analgesics following surgery, and the product is now progressing to certification. For more information: Click here

Older News:

February 2017: Phase 2 Clinical Trial Success for Anugel(™)

A randomised clinical trial has just completed in on 110 patients, found that Anugel(™) cuts the need for analgesics following surgery to remove Class 3 and 4 haemorrhoids, by 33% and reduces pain as measured on the VAS scale by 60%. Anugel(™) delivers a huge improvement in patient comfort. Details of the trials are being submitted for publication in major journals.

August 2016: QA Certified to ISO 9001:2015 and ISO 14001:2015

TUV Rheinland has certified Deep Life Medical Lda to ISO 9001:2015 and ISO 14001:2015. Deep Life Medical is in the process of obtaining ISO EN 13485 certification for its Anugel product, to complete with the ongoing clinical trials of the product.